These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34832678)

  • 1. Prevalence of Hepatitis B and Hepatitis C Infections among Incarcerated Individuals in Iran: A Cross-Sectional National Bio-behavioral Study in 2019.
    Moradi G; Alavian SM; Gholami F; Ramezani R; Ahangarzadeh L; Moradi Y; Sharafi H
    Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832678
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study.
    Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S
    BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.
    Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Boamah I; Adu-Gyamfi C; Asare I; Hesse IF; Mensah G
    BMC Infect Dis; 2008 Mar; 8():33. PubMed ID: 18328097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HIV, hepatitis B virus, and hepatitis C virus among incarcerated people in Iran: a systematic review and meta-analysis.
    Mehmandoost S; Khezri M; Mousavian G; Tavakoli F; Mehrabi F; Sharifi H; Dolan K; Shokoohi M
    Public Health; 2022 Feb; 203():75-82. PubMed ID: 35032918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015.
    Moradi G; Gouya MM; Azimizan Zavareh F; Mohamadi Bolbanabad A; Darvishi S; Aghasadeghi MR; Nabavi M; Alasvand R; Tashakorian M; Nouri B; Rahmani K; Molaei L
    Trop Med Int Health; 2018 Jun; 23(6):641-649. PubMed ID: 29698576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
    SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
    Int J Prison Health; 2023 Feb; ():536-544. PubMed ID: 36757302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of the viral hepatitis B and C in female prisoners of Metropolitan Regional Prison Complex in the State of Goiás, Central Brazil.
    Barros LA; Pessoni GC; Teles SA; Souza SM; Matos MA; Martins RM; Del-Rios NH; Matos MA; Carneiro MA
    Rev Soc Bras Med Trop; 2013; 46(1):24-9. PubMed ID: 23563821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys.
    Rafiee M; Karamouzian M; Sharifi M; Mirzazadeh A; Khezri M; Haghdoost AA; Mehmandoost S; Sharifi H
    Harm Reduct J; 2024 Aug; 21(1):147. PubMed ID: 39138501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Prevalence of Hepatitis B, Hepatitis C, and HIV in Inmates with Drug-Related Convictions in Birjand, Iran in 2008.
    Azarkar Z; Sharifzadeh G
    Hepat Mon; 2010; 10(1):26-30. PubMed ID: 22308122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
    Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ;
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):533-546. PubMed ID: 33965006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Drug Injection in High-Risk Populations of Prisoners with a History of Tattooing: A Cross-Sectional Study.
    Jafari S; Moradi G; Gouya MM; Azimian Zavareh F; Ghaderi E
    J Res Health Sci; 2019 Jan; 19(1):e00435. PubMed ID: 31133625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.
    Okafor IM; Ugwu SO; Okoroiwu HU
    BMC Gastroenterol; 2020 Oct; 20(1):360. PubMed ID: 33126856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and Related Risk Behaviors of Hepatitis C, Hepatitis B and HIV Infections among Male Prisoners in Kermanshah, Iran.
    Khademi N; Skakiba E; Khodadoust M; Khoramdad M
    Arch Iran Med; 2019 Oct; 22(10):588-591. PubMed ID: 31679361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
    J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
    Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
    Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.
    Hennessey KA; Kim AA; Griffin V; Collins NT; Weinbaum CM; Sabin K
    J Urban Health; 2009 Jan; 86(1):93-105. PubMed ID: 18622707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tattooing among Iranian prisoners: results of the two national biobehavioral surveillance surveys in 2015-2016.
    Jafari S; Moradi G; Zareie B; Gouya MM; Zavareh FA; Ghaderi E
    An Bras Dermatol; 2020; 95(3):289-297. PubMed ID: 32276795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study.
    Mirmomen S; Alavian SM; Hajarizadeh B; Kafaee J; Yektaparast B; Zahedi MJ; Zand V; Azami AA; Hosseini MM; Faridi AR; Davari K; Hajibeigi B
    Arch Iran Med; 2006 Oct; 9(4):319-23. PubMed ID: 17061602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran.
    Ramezani A; Amirmoezi R; Volk JE; Aghakhani A; Zarinfar N; McFarland W; Banifazl M; Mostafavi E; Eslamifar A; Sofian M
    AIDS Care; 2014; 26(9):1122-6. PubMed ID: 24499303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.